MALAT1 and non-small cell lung carcinoma: MALAT-1 was found to be a predictive factor for patient survival in stage I NSCLC by Kaplan–Meier analysis which aids in the identification of early-stage NSCLC patients who are very susceptible to metastasis (Ji et al. 2003).